Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869

NCT00733187 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ABT-869

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]